OTO-201 for the Treatment of Otitis Externa

Summary

This is a 1-month, multicenter, open-label study in subjects with unilateral otitis externa. Eligible subjects will receive a single dose of 6 mg OTO-201 to the affected ear. The study is designed to characterize safety, procedural factors and clinical effect of OTO-201 administered in subjects with otitis externa.

Timeline

Start

2015-07

Primary completion

2015-11

Completion

2015-11

Drugs

Indications